Endpoints News

Eli Lilly CEO David Ricks seeks 'exit velocity' for pharma's future

Can Eli Lilly escape the boom-and-bust cycle that has long defined the pharma business?

This report was first published by Endpoints News. To see the original version, click here

Can Eli Lilly escape the boom-and-bust cycle that has long defined the pharma business?

In January, Lilly CEO David Ricks was on stage with Nvidia CEO Jensen Huang. Ricks had recently (if briefly) joined the trillion-dollar club, a rarefied set of corporate chiefs whose companies have touched or exceeded that stratospheric valuation. Huang, a longtime member, wears it with the relaxation of his ever-present leather motorcycle jacket. Ricks, more often found in a sport jacket, is new to the club.

您已阅读7%(589字),剩余93%(7634字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归Endpoints News所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×